← Open Payments lookup

JENNIFER BUTLER ACUFF: Open Payments

NPI 1609910355 · BIRMINGHAM, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$801 in 38 payments from 12 companies in 2025. Trend: 2023 $208 · 2024 $167 · 2025 $801

Food & beverage: $801
CompanyPaymentsAmount
AstraZeneca Pharmaceuticals LP12$265
Regeneron Healthcare Solutions, Inc.8$155
Amgen Inc.5$100
Octapharma USA, Inc.3$62
Takeda Pharmaceuticals U.S.A., Inc.2$45
Novartis Pharmaceuticals Corporation1$32
Genentech USA, Inc.2$31
Ionis Pharmaceuticals, Inc.1$27
GC Biopharma USA, Inc.1$24
CSL Behring1$22

Products named: TEZSPIRE, DUPIXENT, AIRSUPRA, GLASSIA, PANZYGA, Xolair, FASENRA, ALYGLO.

Industry payments across AL — which companies pay providers there.